Questcor, the maker of ACTH said it now estimates that new, paid prescriptions of Acthar for the treatment of certain symptoms of multiple sclerosis rose 160% over those in the third quarter last year to about 850. In addition, Questcor shipped 2,750 vials of Acthar, which also is used to treat other conditions, up 45% from last year’s quarter.
Acthar (repository corticotropin injection) is natural source ACTH (adrenocorticotropic hormone) in 16% gelatin to provide a prolonged release after intramuscular or subcutaneous injection.
Acthar is currently approved in the U.S. for the treatment of acute exacerbations of multiple sclerosis in adults, and as monotherapy for the treatment of infantile spasms in infants and children under 2 years of age. It is also indicated to induce a diuresis or a remission of proteinuria in the nephrotic syndrome without uremia of the idiopathic type or that due to lupus erythematosus, as well as indicated for the treatment of several other diseases and disorders. For a full list of approved indications, please see the Acthar prescribing information.
Questcor is dedicated to supporting patients at each step of the treatment process. With this in mind, Questcor personnel created the Acthar Support and Access Program (A.S.A.P.).
The Acthar Support & Access Program (A.S.A.P.) does the following:
- Contacts the patient’s insurance company
- Investigates benefits and facilitates any prior authorizations if necessary
- Routes the prescription to the appropriate specialty pharmacy for fulfillment
- Ships Acthar and the necessary supplies next day for overnight delivery to the patient’s home or alternate location under the appropriate temperature-controlled conditions
===========================================================
Remain CURRENT with Multiple Sclerosis news and information
REGISTER HERE MS Views and News
.
.Providing You with ‘MS Views and News’, is what we do
.
On the 4th Wednesday of each month
Listen-to StuMSRadio.com at 8pm eastern time.
Each month will feature various guests to be interviewed
Call-in to have (5) minutes of airtime.
Speak about your MS or ask questions
.
“MS Views and News” is a 501©(3) Not-for-Profit organization as recognized by the Internal Revenue Service
.. All contributions are tax deductible to the fullest extent allowed by law
.===========================================================
Disclaimer: ‘MS Views and News’ (MSVN), does not endorse any products or services found on this blog. It is up to you to seek advice from your healthcare provider. The intent of this blog is to provide information on various medical conditions, medications, treatments, and procedures for your personal knowledge and to keep you informed of current health-related issues. It is not intended to be complete or exhaustive, nor is it a substitute for the advice of your physician. Should you or your family members have any specific medical problem, seek medical care promptly.
Visit our MS Learning Channel on YouTube: http://www.youtube.com/msviewsandnews